What makes us The Leader in High Content?
Last Updated on Tuesday, 25 October 2011 21:49
Simply put - more than a decade of experience in image cytometry and high content. In 1998, the first high-content platform (Thermo Scientific ArrayScan VTI HCS Reader) was launched into the early drug discovery market and high-content screening (HCS) was born. Over the last decade, imaging as an assay detection mode has produced novel assays in oncology, neurobiology and in vitro toxicology accelerating the use of new technologies such as RNAi and stem cell models.
- Invented, and commercialized automated image cytometry / high content screening / high content analysis( HCA)
- Developed comprehensive intellectual property portfolio covering HCS.
- Assembled expertise in cell based assay development to train and support users.
- Nurtured the most productive users in HCS and used their feedback to drive innovation.
We consider oursleves as the inventors and global leaders in high-content and our users certainly are the most productive as measured by publications in peer reviewed journals. Our users have published over 450 peer reviewed journal articles since 1997, with 25% from the top 20 most influential journals. That publication rate is five-times the rate of the users of other platforms. (source. Thermo Fisher Scientific Internal Study using the highwire search engine) and we consider thereofre that in terms of publication rate the ArrayScan* VTI HCS Reader is the world's most productive high-content platform.
![]() |
![]() |
|
Thermo Scientific users have published four-times |
Productive use of the ArrayScan* VTI HCS Reader |
To learn more about the research done using the ArrayScan* VTI HCS Reader and other Thermo Scientific high-content platforms download our High Content Application Collection from the link below, or visit our HCSLibrary and explore for yourself.

What makes us The Leader in High Content?




